Targeting metabolic pathways to treat cardiovascular diseases

Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165879. doi: 10.1016/j.bbadis.2020.165879. Epub 2020 Jun 18.

Authors

Jan F C Glatz¹, Coert J Zuurbier², Terje S Larsen³

Affiliations

¹ Maastricht University, Maastricht, the Netherlands. Electronic address: glatz@maastrichtuniversity.nl.
² Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address: c.j.zuurbier@amsterdamumc.nl.
³ The Arctic University of Norway, Tromsø, Norway. Electronic address: terje.larsen@uit.no.

PMID: 32562699
DOI: 10.1016/j.bbadis.2020.165879

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Cardiovascular Diseases / drug therapy*
Cardiovascular Diseases / metabolism
Congresses as Topic
Energy Metabolism / drug effects
Heart / drug effects
Humans
Metabolic Networks and Pathways / drug effects*
Myocardial Contraction / drug effects
Myocardium / metabolism
Protein Kinase Inhibitors / pharmacology
Protein Kinase Inhibitors / therapeutic use
Societies, Medical
Sodium-Glucose Transporter 2 Inhibitors / pharmacology
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

Protein Kinase Inhibitors
Sodium-Glucose Transporter 2 Inhibitors